ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for IRWD

Stock NameIronwood Pharmaceuticals Inc
TickerIRWD(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS46333X1081
LEI549300PC8MR6QHH6P296

Show aggregate IRWD holdings

News associated with IRWD

Ironwood Pharmaceuticals (NASDAQ:IRWD) & Reviva Pharmaceuticals (NASDAQ:RVPH) Critical Comparison
Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Free Report) and Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, dividends and valuation. Insider and Institutional Ownership 63.2% of Reviva […] - 2025-09-11 04:46:30
Pacer Advisors Inc. Sells 9,941,673 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)
Pacer Advisors Inc. reduced its stake in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 84.7% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 1,789,098 shares of the biotechnology company’s stock after selling 9,941,673 shares during the period. Pacer Advisors Inc.’s holdings in Ironwood Pharmaceuticals were worth $2,630,000 as of its […] - 2025-07-30 05:36:49
Cerity Partners LLC Buys New Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)
Cerity Partners LLC bought a new position in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) in the first quarter, HoldingsChannel.com reports. The institutional investor bought 96,478 shares of the biotechnology company’s stock, valued at approximately $142,000. Other large investors also recently bought and sold shares of the company. Point72 Asia Singapore Pte. Ltd. […] - 2025-07-30 04:44:43
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives Consensus Recommendation of “Hold” from Analysts
Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) have been assigned an average rating of “Hold” from the eight brokerages that are covering the company, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 1 […] - 2025-07-25 05:14:52
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 6.4% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 286,990 shares of the biotechnology company’s stock after purchasing an additional […] - 2025-06-10 04:29:01
Two Sigma Investments LP Lowers Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)
Two Sigma Investments LP reduced its position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 3.1% in the fourth quarter, Holdings Channel.com reports. The fund owned 863,428 shares of the biotechnology company’s stock after selling 27,535 shares during the period. Two Sigma Investments LP’s holdings in Ironwood Pharmaceuticals were worth $3,825,000 as of its […] - 2025-05-29 05:12:56
Comerica Bank Sells 28,108 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)
Comerica Bank lessened its holdings in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 18.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 122,083 shares of the biotechnology company’s stock after selling 28,108 shares during the period. Comerica Bank owned […] - 2025-05-15 04:52:50
Tower Research Capital LLC TRC Boosts Stock Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)
Tower Research Capital LLC TRC increased its position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 1,130.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,521 shares of the biotechnology company’s stock after buying an additional 16,097 shares during the quarter. […] - 2025-05-11 06:36:52
XTX Topco Ltd Invests $203,000 in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)
XTX Topco Ltd bought a new position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund bought 45,881 shares of the biotechnology company’s stock, valued at approximately $203,000. Other institutional investors have also recently modified their holdings of the company. Journey Strategic Wealth LLC purchased a new stake […] - 2025-04-28 05:11:01
Ironwood Raises 2025 Adj. EBITDA Outlook
(RTTNews) - Ironwood Pharmaceuticals (IRWD) reiterated full year 2025 LINZESS U.S. net sales and total Ironwood revenue guidance and increased adjusted EBITDA guidance. The company has raised full-year 2025 adjusted EBITDA guidance to greater than $105 million as it no longer pla - 2025-04-25 08:22:36
Federated Hermes Inc. Makes New Investment in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)
Federated Hermes Inc. purchased a new position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 370,476 shares of the biotechnology company’s stock, valued at approximately $1,641,000. Federated Hermes Inc. owned […] - 2025-04-15 04:54:50
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives $8.60 Consensus Price Target from Brokerages
Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) have earned a consensus rating of “Moderate Buy” from the six analysts that are covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 month […] - 2025-04-14 03:01:00
Intech Investment Management LLC Acquires 13,205 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)
Intech Investment Management LLC boosted its holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 30.0% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 57,244 shares of the biotechnology company’s stock after buying an additional 13,205 shares during the quarter. Intech Investment […] - 2025-03-27 06:28:55
15,147 Shares in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Acquired by Y Intercept Hong Kong Ltd
Y Intercept Hong Kong Ltd acquired a new position in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) in the 4th quarter, HoldingsChannel.com reports. The fund acquired 15,147 shares of the biotechnology company’s stock, valued at approximately $67,000. A number of other institutional investors also recently bought and sold shares of IRWD. Pacer Advisors […] - 2025-03-06 08:44:39

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) IRWD holdings

DateNumber of IRWD Shares HeldBase Market Value of IRWD SharesLocal Market Value of IRWD SharesChange in IRWD Shares HeldChange in IRWD Base ValueCurrent Price per IRWD Share HeldPrevious Price per IRWD Share Held
2025-12-03 (Wednesday)121,220IRWD holding increased by 14742USD 452,151IRWD holding increased by 79478USD 452,15114,742USD 79,478 USD 3.73 USD 3.5
2025-12-02 (Tuesday)106,478IRWD holding increased by 3885USD 372,673IRWD holding increased by 13597USD 372,6733,885USD 13,597 USD 3.5 USD 3.5
2025-12-01 (Monday)102,593USD 359,076USD 359,0760USD 0 USD 3.5 USD 3.5
2025-11-28 (Friday)102,593IRWD holding increased by 259USD 359,076IRWD holding decreased by -35933USD 359,076259USD -35,933 USD 3.5 USD 3.86
2025-11-27 (Thursday)102,334IRWD holding increased by 780USD 395,009IRWD holding increased by 3011USD 395,009780USD 3,011 USD 3.86 USD 3.86
2025-11-26 (Wednesday)101,554USD 391,998IRWD holding increased by 74134USD 391,9980USD 74,134 USD 3.86 USD 3.13
2025-11-25 (Tuesday)101,554IRWD holding increased by 1300USD 317,864IRWD holding decreased by -14979USD 317,8641,300USD -14,979 USD 3.13 USD 3.32
2025-11-24 (Monday)100,254IRWD holding increased by 261USD 332,843IRWD holding increased by 16865USD 332,843261USD 16,865 USD 3.32 USD 3.16
2025-11-21 (Friday)99,993USD 315,978IRWD holding decreased by -1000USD 315,9780USD -1,000 USD 3.16 USD 3.17
2025-11-20 (Thursday)99,993IRWD holding decreased by -1032USD 316,978IRWD holding decreased by -4282USD 316,978-1,032USD -4,282 USD 3.17 USD 3.18
2025-11-19 (Wednesday)101,025IRWD holding increased by 258USD 321,260IRWD holding increased by 7875USD 321,260258USD 7,875 USD 3.18 USD 3.11
2025-11-18 (Tuesday)100,767IRWD holding increased by 1548USD 313,385IRWD holding increased by 2830USD 313,3851,548USD 2,830 USD 3.11 USD 3.13
2025-11-17 (Monday)99,219IRWD holding increased by 516USD 310,555IRWD holding increased by 628USD 310,555516USD 628 USD 3.13 USD 3.14
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of IRWD by Blackrock for IE00BYXG2H39

Show aggregate share trades of IRWD

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-03BUY14,7423.7693.410 3.446USD 50,799 1.87
2025-12-02BUY3,8853.5503.360 3.379USD 13,127 1.86
2025-11-28BUY2593.9303.400 3.453USD 894 1.84
2025-11-27BUY780 3.860* 1.83
2025-11-25BUY1,3003.3403.065 3.093USD 4,020 1.82
2025-11-24BUY2613.3953.170 3.193USD 833 1.81
2025-11-20SELL-1,0323.4403.050 3.089USD -3,188 1.80 Loss of -1,334 on sale
2025-11-19BUY2583.3002.995 3.025USD 781 1.79
2025-11-18BUY1,5483.1902.960 2.983USD 4,618 1.78
2025-11-17BUY5163.4703.010 3.056USD 1,577 1.78
2025-11-14BUY2573.4243.120 3.150USD 810 1.77
2025-11-12BUY2583.2302.860 2.897USD 747 1.75
2025-11-11BUY2602.9752.400 2.458USD 639 1.75
2025-11-06BUY2592.0751.950 1.962USD 508 1.74
2025-11-04BUY2621.8901.760 1.773USD 465 1.74
2025-10-30BUY1,3201.5801.470 1.481USD 1,956 1.74
2025-10-29BUY5281.5101.650 1.636USD 864 1.74
2025-10-22SELL-1,0401.5701.590 1.588USD -1,652 1.74 Profit of 163 on sale
2025-10-20BUY5201.5401.550 1.549USD 805 1.75
2025-10-17BUY1,2951.4301.570 1.556USD 2,015 1.75
2025-10-15BUY2,0481.6101.620 1.619USD 3,316 1.75
2025-10-03BUY1,8411.5501.730 1.712USD 3,152 1.75
2025-10-02BUY2631.6101.610 1.610USD 423 1.75
2025-09-30BUY5261.3101.460 1.445USD 760 1.76
2025-09-26BUY5261.3901.400 1.399USD 736 1.76
2025-09-25BUY5241.2701.360 1.351USD 708 1.76
2025-09-24BUY11.3701.410 1.406USD 1 1.77
2025-09-18BUY2611.4601.460 1.460USD 381 1.77
2025-09-17BUY7861.2801.350 1.343USD 1,056 1.77
2025-08-20SELL-1,0481.1001.120 1.118USD -1,172 1.78 Profit of 698 on sale
2025-07-30BUY1,0480.8300.950 0.938USD 983 1.81
2025-07-17SELL-5240.7900.820 0.817USD -428 1.87 Profit of 554 on sale
2025-07-11SELL-2,1040.7500.810 0.804USD -1,692 1.91 Profit of 2,318 on sale
2025-07-07BUY7890.7100.760 0.755USD 596 1.94
2025-07-02BUY14,3550.7400.750 0.749USD 10,752 1.95
2025-06-11BUY1,0420.7200.800 0.792USD 825 2.03
2025-06-04SELL-2610.6000.630 0.627USD -164 2.09 Profit of 381 on sale
2025-04-23BUY2600.7700.830 0.824USD 214 2.50
2025-04-10SELL-2,0881.0101.070 1.064USD -2,222 2.68 Profit of 3,368 on sale
2025-04-08SELL-2611.1101.290 1.272USD -332 2.71 Profit of 376 on sale
2025-04-07SELL-2611.2701.310 1.306USD -341 2.73 Profit of 372 on sale
2025-04-04SELL-1,3051.3401.360 1.358USD -1,772 2.75 Profit of 1,813 on sale
2025-04-01BUY1,0441.4101.480 1.473USD 1,538 2.78
2025-03-31SELL-7831.4701.510 1.506USD -1,179 2.80 Profit of 1,009 on sale
2025-03-14SELL-4,1921.4901.550 1.544USD -6,472 3.00 Profit of 6,101 on sale
2025-03-07SELL-5241.5001.610 1.599USD -838 3.11 Profit of 794 on sale
2025-03-04SELL-2621.4901.570 1.562USD -409 3.19 Profit of 426 on sale
2025-02-25BUY5241.7401.830 1.821USD 954 3.32
2025-02-19SELL-2621.9402.050 2.039USD -534 3.43 Profit of 365 on sale
2025-02-13BUY7862.0102.040 2.037USD 1,601 3.55
2025-02-12BUY2621.9402.010 2.003USD 525 3.58
2025-02-11BUY1,0441.8801.900 1.898USD 1,982 3.62
2024-12-30SELL-8,3754.3804.500 4.488USD -37,587 3.93 Loss of -4,682 on sale
2024-11-18SELL-4,1584.0204.200 4.182USD -17,389 4.29 Profit of 443 on sale
2024-11-08SELL-2774.9604.970 4.969USD -1,376 4.23 Loss of -204 on sale
2024-10-21SELL-2804.1904.400 4.379USD -1,226 0.00 Loss of -1,226 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of IRWD

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19141,8100387,88036.6%
2025-09-18201,7210590,26234.2%
2025-09-1779,743200268,37529.7%
2025-09-1679,5270334,08523.8%
2025-09-15124,2540303,02941.0%
2025-09-12132,9230384,98834.5%
2025-09-11157,3530590,76726.6%
2025-09-10110,6240698,41615.8%
2025-09-0997,0630339,04028.6%
2025-09-0869,5370286,20324.3%
2025-09-0581,87835,145423,73919.3%
2025-09-04539,69785,8071,569,94134.4%
2025-09-03241,44716,317910,44226.5%
2025-09-0265,3060447,26114.6%
2025-08-29147,1720298,17749.4%
2025-08-28126,8561,200506,75625.0%
2025-08-2758,3590228,70025.5%
2025-08-26114,6260393,07429.2%
2025-08-25255,5420664,42438.5%
2025-08-22559,60120,5331,700,79432.9%
2025-08-21200,5480815,35224.6%
2025-08-20115,2906,000507,82622.7%
2025-08-19257,314337681,02337.8%
2025-08-18204,0810525,35038.8%
2025-08-15174,649300468,39937.3%
2025-08-14355,504630652,05554.5%
2025-08-13603,764361,482,46040.7%
2025-08-12298,728184763,18739.1%
2025-08-11813,17960,7921,133,95371.7%
2025-08-08364,839143589,98961.8%
2025-08-071,614,81615,6583,350,17948.2%
2025-08-06277,4764,783508,30754.6%
2025-08-05230,7851,262464,07949.7%
2025-08-04228,908264502,24545.6%
2025-08-01320,3154,506585,49554.7%
2025-07-31306,5181,327535,47657.2%
2025-07-30285,9541,900616,87346.4%
2025-07-29702,6943,3751,651,96742.5%
2025-07-28226,5521,237485,24046.7%
2025-07-25126,2372,697356,40235.4%
2025-07-24232,218864800,29729.0%
2025-07-23350,8893,404868,21240.4%
2025-07-22213,8081,093524,86840.7%
2025-07-21163,0283,421321,23850.7%
2025-07-18318,6364,280634,36150.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy